<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://retacompare.com/news/retatrutide-emerges-as-a-potentially-powerful-weight-loss-drug</loc>
    <lastmod>2026-10-30T03:13:00.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T03:13:00.000Z</news:publication_date>
      <news:title>Retatrutide Emerges as a Potentially Powerful Weight Loss Drug</news:title>
      <news:keywords>Weight Loss, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/impact-of-glp-1-drugs-on-us-healthcare-and-public-health-explored</loc>
    <lastmod>2026-10-29T23:51:59.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T23:51:59.000Z</news:publication_date>
      <news:title>Impact of GLP-1 Drugs on US Healthcare and Public Health Explored</news:title>
      <news:keywords>Market News, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/potential-long-term-side-effects-of-glp-1-drugs-highlighted-by-doctor</loc>
    <lastmod>2026-10-29T17:56:42.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T17:56:42.000Z</news:publication_date>
      <news:title>Potential Long-Term Side Effects of GLP-1 Drugs Highlighted by Doctor</news:title>
      <news:keywords>Weight Loss, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/financial-implications-of-glp-1-agonists-in-metabolic-treatments</loc>
    <lastmod>2026-10-29T14:37:29.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T14:37:29.000Z</news:publication_date>
      <news:title>Financial Implications of GLP-1 Agonists in Metabolic Treatments</news:title>
      <news:keywords>Market News, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/oura-and-uc-san-diego-health-to-analyze-glp-1-impact-with-smart-ring-data</loc>
    <lastmod>2026-10-29T12:00:00.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T12:00:00.000Z</news:publication_date>
      <news:title>Oura and UC San Diego Health to Analyze GLP-1 Impact with Smart Ring Data</news:title>
      <news:keywords>Patient Experiences, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/retatrutide-outperforms-semaglutide-in-phase-3-a1c-and-weight-results</loc>
    <lastmod>2026-10-29T06:33:45.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T06:33:45.000Z</news:publication_date>
      <news:title>Retatrutide Outperforms Semaglutide in Phase 3 A1C and Weight Results</news:title>
      <news:keywords>Clinical Trials, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/eli-lilly-s-retatrutide-trial-news-affects-stock-valuation</loc>
    <lastmod>2026-10-29T00:12:00.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T00:12:00.000Z</news:publication_date>
      <news:title>Eli Lilly&apos;s Retatrutide Trial News Affects Stock Valuation</news:title>
      <news:keywords>Market News, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/analysis-compares-adverse-events-of-semaglutide-and-tirzepatide</loc>
    <lastmod>2026-10-29T00:00:00.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T00:00:00.000Z</news:publication_date>
      <news:title>Analysis Compares Adverse Events of Semaglutide and Tirzepatide</news:title>
      <news:keywords>Clinical Trials, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/comparative-cardiovascular-risk-of-semaglutide-in-cancer-survivors</loc>
    <lastmod>2026-10-29T00:00:00.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T00:00:00.000Z</news:publication_date>
      <news:title>Comparative Cardiovascular Risk of Semaglutide in Cancer Survivors</news:title>
      <news:keywords>Clinical Trials, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/digital-food-purchases-respond-to-glp-1-therapy-in-obesity-study</loc>
    <lastmod>2026-10-29T00:00:00.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T00:00:00.000Z</news:publication_date>
      <news:title>Digital Food Purchases Respond to GLP-1 Therapy in Obesity Study</news:title>
      <news:keywords>Patient Experiences, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/evaluating-obesity-medications-in-older-adults-using-geriatrics-5ms-framework</loc>
    <lastmod>2026-10-29T00:00:00.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T00:00:00.000Z</news:publication_date>
      <news:title>Evaluating Obesity Medications in Older Adults Using Geriatrics 5Ms Framework</news:title>
      <news:keywords>Weight Loss, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/retatrutide-shows-superior-a1c-weight-loss-over-semaglutide-in-trial</loc>
    <lastmod>2026-10-28T22:40:25.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T22:40:25.000Z</news:publication_date>
      <news:title>Retatrutide Shows Superior A1C, Weight Loss Over Semaglutide in Trial</news:title>
      <news:keywords>Clinical Trials, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/retatrutide-shows-superior-weight-loss-in-diabetes-compared-to-ozempic-in-trial</loc>
    <lastmod>2026-10-28T19:51:26.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T19:51:26.000Z</news:publication_date>
      <news:title>Retatrutide Shows Superior Weight Loss in Diabetes Compared to Ozempic in Trial</news:title>
      <news:keywords>Clinical Trials, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/retatrutide-outperforms-ozempic-in-direct-comparative-trial</loc>
    <lastmod>2026-10-28T17:26:15.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T17:26:15.000Z</news:publication_date>
      <news:title>Retatrutide Outperforms Ozempic in Direct Comparative Trial</news:title>
      <news:keywords>Clinical Trials, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/retatrutide-surpasses-ozempic-in-weight-loss-and-glucose-control-trial</loc>
    <lastmod>2026-10-28T16:38:00.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T16:38:00.000Z</news:publication_date>
      <news:title>Retatrutide Surpasses Ozempic in Weight Loss and Glucose Control Trial</news:title>
      <news:keywords>Clinical Trials, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/retatrutide-surpasses-ozempic-in-diabetes-trial-but-shows-more-side-effects</loc>
    <lastmod>2026-10-28T15:53:00.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T15:53:00.000Z</news:publication_date>
      <news:title>Retatrutide Surpasses Ozempic in Diabetes Trial but Shows More Side Effects</news:title>
      <news:keywords>Clinical Trials, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/potential-sleep-benefits-of-weight-loss-drug-explored</loc>
    <lastmod>2026-10-28T11:00:59.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T11:00:59.000Z</news:publication_date>
      <news:title>Potential Sleep Benefits of Weight-Loss Drug Explored</news:title>
      <news:keywords>Weight Loss, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/retatrutide-shows-superior-a1c-and-weight-loss-in-trial-against-ozempic</loc>
    <lastmod>2026-10-28T10:45:17.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T10:45:17.000Z</news:publication_date>
      <news:title>Retatrutide Shows Superior A1C and Weight Loss in Trial Against Ozempic</news:title>
      <news:keywords>Clinical Trials, Retatrutide</news:keywords>
    </news:news>
  </url>
</urlset>
